DEFINE-PCI Study: 60 Second Insights
Published: 20 March 2019
-
Views:
10
-
Likes:
7
-
Views:
10
-
Likes:
7
-
Up Next
-
Part 4 | Session 1 Justin Davies
-
Part 4 | Session 2 Allen Jeremias
-
Part 4 | Session 3 Takashi Akasaka
-
Part 4 | Session 4 Bruce Samuels
-
Part 5 | Session 1 Justin Davies
-
Part 5 | Session 2 Allen Jeremias
-
Part 6 | Session 1 Justin Davies
-
Part 6 | Session 2 Allen Jeremias
-
Part 7 | Session 1 Justin Davies
-
Part 7 | Session 2 Allen Jeremias
-
Part 8 | Session 1 Justin Davies
-
Part 8 | Session 2 Allen Jeremias
-
Part 8 | Session 3 Takashi Akasaka
-
Part 8 | Session 4 Bruce Samuels
-
Part 9 | Session 1 Justin Davies
-
Part 9 | Session 2 Allen Jeremias
-
Part 9 | Session 3 Takashi Akasaka
-
Part 9 | Session 4 Bruce Samuels
-
Part 10 | Session 1 Justin Davies
-
Part 10 | Session 2 Allen Jeremias
-
Part 10 | Session 3 Takashi Akasaka
-
Part 10 | Session 4 Bruce Samuels
-
Part 11 | Session 1 Justin Davies
-
Part 11 | Session 2 Allen Jeremias
-
Part 11 | Session 3 Takashi Akasaka
-
Part 11 | Session 4 Bruce Samuels
-
Part 12 | Session 1 Justin Davies
-
Part 12 | Session 2 Allen Jeremias
-
Part 12 | Session 3 Takashi Akasaka
-
Part 12 | Session 4 Bruce Samuels
-
Part 1 | Session 1 Justin Davies Justin E Davies
-
Part 1 | Session 2 Allen Jeremias Allen Jeremias
-
Part 1 | Session 3 Takashi Akasaka Takashi Akasaka
-
Part 1 | Session 4 Bruce Samuels Bruce Samuels
-
Part 2 | Session 1 Justin Davies Justin E Davies
-
Part 2 | Session 2 Allen Jeremias Allen Jeremias
-
Part 2 | Session 3 Takashi Akasaka Takashi Akasaka
-
Part 2 | Session 4 Bruce Samuels Bruce Samuels
-
Part 3 | Session 1 Justin Davies Justin E Davies
-
Part 3 | Session 2 Allen Jeremias Allen Jeremias
-
Part 3 | Session 3 Takashi Akasaka Takashi Akasaka
Overview
A series of 60-second interviews where Justin Davies, Allen Jeremias, Takashi Akasaka and Bruce Samuels provide their thoughts on the DEFINE-FLAIR Study.
More from this programme
Part 1
How has Define-FLAIR affected your clinical practice?
Part 2
In what kind of scenarios would residual ischaemia be addressable or not?
Part 3
How does residual ischaemia impact the healthcare system?
Part 4
What has been your experience with tools like iFR co-registration?
Part 5
What's next in the research pipeline?
| 2 sessions | |
| Justin Davies | Watch now |
| Allen Jeremias | Watch now |
Part 6
How will it change your clinical practice?
| 2 sessions | |
| Justin Davies | Watch now |
| Allen Jeremias | Watch now |
Part 7
What were the key findings from DEFINE-PCI?
| 2 sessions | |
| Justin Davies | Watch now |
| Allen Jeremias | Watch now |
Part 8
Do you think the broader interventional community believes post-PCI ischaemia is a real problem?
Part 9
How is DEFINE PCI different from earlier post-PCI ischaemia studies?
Part 10
Why was DEFINE PCI done, is there precedent for post-PCI ischaemia?
Part 11
What would be surprising to see from DEFINE PCI?
Part 12